`
`Voice of the Pharmacist
`
`Source: SDI’s Vector One®: National
`2010 Top 200 branded drugs by retail dollars
`
`Rank
`
`Drug
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`26
`27
`28
`29
`30
`31
`32
`33
`34
`35
`
`Nexium
`Lipitor
`Plavix
`Advair Diskus
`OxyContin
`Abilify
`Singulair
`Seroquel
`Crestor
`Cymbalta
`Actos
`Lexapro
`Zyprexa
`Spiriva
`Lantus
`Aricept
`Lyrica
`Diovan
`Effexor XR
`Concerta
`Levaquin
`Celebrex
`Diovan HCT
`Januvia
`Suboxone
`NovoLog
`Viagra
`Atripla
`Tricor
`Provigil
`Zetia
`Geodon oral
`Vytorin
`Ambien CR
`Lunesta
`
`Total
`retail dollars
`5,276,153,419
`5,272,576,974
`4,675,483,238
`3,655,206,486
`3,554,751,453
`3,514,265,569
`3,324,909,086
`3,222,055,403
`2,922,687,785
`2,638,536,458
`2,631,930,396
`2,483,391,305
`2,036,092,406
`1,593,593,745
`1,525,697,545
`1,522,517,815
`1,478,158,338
`1,443,539,325
`1,431,042,602
`1,407,962,235
`1,355,350,876
`1,349,833,667
`1,314,507,914
`1,294,408,018
`1,164,872,171
`1,101,447,959
`1,028,769,049
`1,028,753,929
`1,015,682,350
`999,975,648
`985,823,012
`959,057,723
`953,625,397
`951,108,005
`948,621,624
`
`% Change from
`previous year
`4.9%
`-2.3%
`10.2%
`-1.0%
`13.1%
`12.7%
`8.9%
`2.4%
`27.0%
`7.6%
`4.2%
`4.6%
`7.7%
`19.3%
`0.3%
`13.3%
`-0.1%
`7.0%
`-40.1%
`16.9%
`-0.6%
`-6.9%
`3.7%
`13.0%
`26.6%
`20.6%
`5.5%
`-6.5%
`-17.2%
`6.7%
`-4.3%
`8.7%
`-16.3%
`-2.5%
`17.6%
`
`Rank
`
`Drug
`
`36
`37
`38
`39
`40
`41
`42
`43
`44
`45
`46
`47
`48
`49
`50
`51
`52
`53
`54
`55
`56
`57
`58
`59
`60
`61
`62
`63
`64
`65
`66
`67
`68
`69
`70
`
`Lidoderm
`Lantus SoloSTAR
`Vyvanse
`Aciphex
`Nasonex
`Lovenox
`Adderall XR
`ProAir HFA
`Truvada
`Niaspan
`Humalog
`Cialis
`Namenda
`Symbicort
`Flovent HFA
`Seroquel XR
`Combivent
`Lovaza
`Solodyn
`Detrol LA
`AndroGel
`Benicar
`Levemir
`Enbrel
`Valtrex
`Benicar HCT
`Gleevec
`Humira Pen
`Synthroid
`Xalatan
`Premarin tabs
`Strattera
`Ventolin HFA
`Flomax
`Loestrin 24 Fe
`
`1 Drug topicS
`
` June 2011
`
`% Change from
`previous year
`-1.1%
`50.5%
`40.9%
`-8.8%
`-1.9%
`-20.4%
`-27.0%
`-12.6%
`-8.5%
`11.0%
`3.2%
`15.9%
`10.9%
`47.4%
`13.2%
`92.1%
`14.3%
`15.5%
`40.7%
`-13.6%
`10.1%
`10.0%
`41.1%
`-15.8%
`-69.9%
`-3.1%
`-3.7%
`10.1%
`2.5%
`9.1%
`-6.5%
`-3.9%
`65.4%
`-68.9%
`82.3%
`
`Total
`retail dollars
`934,418,905
`933,589,533
`931,421,098
`915,796,557
`886,446,374
`867,240,138
`837,448,101
`818,903,506
`813,944,833
`793,882,590
`783,294,359
`756,576,861
`744,296,688
`707,468,440
`704,631,858
`695,560,552
`693,068,137
`682,384,410
`673,427,474
`620,231,325
`593,780,041
`567,636,890
`567,341,731
`546,814,765
`533,961,845
`526,177,275
`517,967,065
`514,735,868
`506,859,926
`502,227,925
`497,757,239
`496,960,100
`496,659,340
`486,106,611
`483,754,224
`Exhibit 1073
`IPR2017-00807
`ARGENTUM
`
`DrugTopics .com
`
`000001
`
`
`
`®
`
`Voice of the Pharmacist
`
`Source: SDI’s Vector One®: National
`2010 Top 200 branded drugs by retail dollars
`
`Rank
`
`Drug
`
`71
`72
`73
`74
`75
`76
`77
`78
`79
`80
`81
`82
`83
`84
`85
`86
`87
`88
`89
`90
`91
`92
`93
`94
`95
`96
`97
`98
`99
`100
`101
`102
`103
`104
`105
`
`Protonix
`Boniva
`Restasis
`Femara
`Enbrel Sureclick
`NovoLog Mix 70/30
`Evista
`Byetta
`Janumet
`Asacol
`Avodart
`Vesicare
`Trilipix
`Copaxone
`Focalin XR
`Reyataz
`Pristiq
`Arimidex
`Chantix
`Sensipar
`Avapro
`Opana ER
`Yaz
`Doryx
`Actoplus Met
`Humira
`Avelox
`NuvaRing
`Renvela
`Ortho Tri-Cyclen Lo
`Lamictal
`Avalide
`Xopenex
`Actonel
`Dexilant/Kapidex
`
`Total
`retail dollars
`481,429,742
`480,470,301
`480,414,900
`477,256,816
`474,602,259
`470,786,920
`469,013,238
`459,454,780
`459,068,664
`450,645,695
`441,486,603
`440,862,092
`428,978,587
`421,758,012
`416,245,820
`412,293,572
`411,715,185
`403,891,082
`394,944,444
`382,232,873
`369,596,647
`366,417,404
`361,958,005
`361,662,633
`359,790,142
`358,012,620
`353,130,091
`349,014,921
`333,987,023
`331,730,832
`326,331,453
`324,571,337
`316,162,268
`313,904,787
`313,386,619
`
`% Change from
`previous year
`3.5%
`-5.3%
`19.0%
`12.7%
`2.6%
`16.8%
`0.3%
`-17.8%
`22.7%
`-8.3%
`5.5%
`15.3%
`104.5%
`1.3%
`18.6%
`-20.9%
`58.4%
`-37.5%
`-14.3%
`-0.5%
`-6.2%
`52.5%
`-49.1%
`35.7%
`4.7%
`-12.5%
`-8.4%
`11.0%
`111.5%
`33.9%
`-35.2%
`-6.4%
`-13.0%
`-29.0%
`254.8%
`
`Rank
`
`Drug
`
`106
`Lotrel
`107
`Invega
`108 Welchol
`109
`Avonex
`110
`Topamax
`111
`Norvir
`112
`Entocort EC
`113
`Aggrenox
`114
`Travatan Z
`115
`Isentress
`116
`Avandia
`117
`Prevacid SoluTab
`118
`Exforge
`119
`Cozaar
`120
`Lumigan
`121
`Caduet
`122
`Actonel 150
`123
`Risperdal Consta
`124
`Prograf
`125
`Ciprodex otic
`126
`Vigamox
`127
`Kadian
`128
`Coreg CR
`129
`Levitra
`130
`Maxalt
`131
`Keppra
`132
`Prevacid
`133
`Micardis
`134
`Bystolic
`135
`Prezista
`136
`Exelon Patch
`137
`Nuvigil
`138
`Zyvox
`139
`Lialda
`140
`Epzicom
`
`Total
`retail dollars
`306,010,840
`304,182,402
`303,392,458
`303,147,918
`287,186,120
`287,102,342
`282,547,676
`277,144,956
`273,598,310
`272,132,268
`269,213,102
`268,284,576
`267,771,801
`267,081,517
`267,047,653
`266,967,071
`264,858,113
`262,054,266
`260,885,600
`254,888,384
`252,864,158
`251,858,580
`251,440,410
`242,446,663
`242,237,305
`241,737,771
`241,374,337
`238,335,490
`231,449,953
`230,406,897
`229,601,920
`223,885,811
`222,554,953
`222,201,367
`221,406,518
`
`% Change from
`previous year
`-6.8%
`5.1%
`19.7%
`0.2%
`-70.5%
`-10.0%
`38.6%
`6.5%
`44.1%
`-9.8%
`-33.8%
`-1.4%
`16.6%
`-62.4%
`7.0%
`-18.6%
`26.2%
`-8.2%
`-56.2%
`13.8%
`11.3%
`-0.8%
`-1.6%
`-5.9%
`0.5%
`-33.0%
`-90.6%
`23.9%
`72.2%
`13.8%
`38.2%
`239.6%
`-7.5%
`29.3%
`-17.0%
`
`2 Drug topicS June 2011
`
`DrugTopics .com
`
`000002
`
`
`
`®
`
`Voice of the Pharmacist
`
`Source: SDI’s Vector One®: National
`2010 Top 200 branded drugs by retail dollars
`
`Rank
`
`Drug
`
`141
`142
`143
`144
`145
`146
`147
`
`Enablex
`Forteo
`Viread
`Kaletra
`Micardis HCT
`Maxalt MLT
`Humalog Mix
`75/25 Pen
`148
`Xeloda
`149
`Asmanex
`150
`Hyzaar
`151
`Fentora
`152
`Pulmicort Respules
`153
`Ranexa
`154
`RenaGel
`155
`Prempro
`156
`Relpax
`157
`Patanol
`158
`Amitiza
`159
`Duragesic
`160
`Vancocin HCl
`161
`Nasacort AQ
`162
`Proventil HFA
`163
`Advair HFA
`164
`Valcyte
`165 Wellbutrin XL
`166
`Oracea
`167
`Vivelle-DOT
`168
`Uroxatral
`169
`Zovirax topical
`170
`Epipen
`
`Total
`retail dollars
`220,478,278
`219,387,367
`216,264,393
`212,723,964
`211,575,086
`211,230,635
`
`% Change from
`previous year
`11.0%
`-25.1%
`-6.2%
`-32.9%
`10.4%
`-1.1%
`
`211,021,183
`209,499,425
`208,839,180
`207,471,115
`207,376,157
`205,218,758
`200,622,817
`199,275,383
`198,132,493
`197,341,500
`196,500,889
`195,132,681
`194,599,467
`192,066,919
`192,035,569
`191,839,105
`191,245,407
`191,160,942
`189,026,585
`187,182,546
`185,860,221
`185,624,396
`184,377,339
`182,785,890
`
`-6.9%
`-11.7%
`3.8%
`-62.3%
`11.2%
`-68.0%
`41.5%
`-48.2%
`22.2%
`-3.4%
`2.6%
`1.4%
`-14.5%
`23.4%
`-19.0%
`-26.5%
`26.4%
`-0.9%
`-21.2%
`67.9%
`12.4%
`6.2%
`2.6%
`20.8%
`
`Rank
`
`Drug
`
`171
`Creon
`172
`Azor
`173
`Pentasa
`174
`Procrit
`175
`Pataday
`176
`Differin
`177
`Premarin vaginal
`178
`Zyprexa Zydis
`179
`Tussionex
`180
`Victoza
`181
`Humalog KwikPen
`182
`Arixtra
`183
`Qvar
`184
`Combivir
`185
`Testim
`186
`Tarceva
`187
`Xyzal
`188
`Elmiron
`189
`Propecia
`190
`CellCept
`191
`Skelaxin
`192
`Betaseron
`193
`Temodar
`194
`Flector
`195
`Pegasys
`196
`Prandin
`197
`Veramyst
`198
`Intuniv
`199
`Clobex
`200
`Humulin N
`Abbreviation: NA, not applicable.
`
`Total
`retail dollars
`181,303,156
`179,647,493
`178,068,686
`174,622,884
`173,553,930
`171,454,164
`170,860,686
`169,714,740
`169,611,499
`168,943,334
`168,270,030
`165,530,857
`163,697,198
`163,406,344
`163,015,679
`160,591,405
`160,237,468
`158,274,339
`157,892,792
`157,743,921
`156,372,879
`155,952,005
`154,466,774
`153,814,512
`153,101,276
`151,678,809
`150,582,938
`150,346,757
`150,230,784
`149,945,472
`
`% Change from
`previous year
`358.6%
`33.0%
`4.5%
`-25.9%
`25.5%
`-24.8%
`3.5%
`6.7%
`-29.8%
`NA
`79.6%
`19.9%
`41.1%
`-27.8%
`12.2%
`-38.2%
`-15.6%
`4.3%
`-5.7%
`-68.3%
`-67.7%
`-6.8%
`-14.9%
`0.2%
`-8.4%
`-5.9%
`-7.8%
`>999
`20.6%
`4.4%
`
`3 Drug topicS June 2011
`
`DrugTopics .com
`
`000003
`
`